Evidence map›Paper›PMID 35013914›Full record

ArticleCancer causes & control : CCC2022

Methods and implementation of a Hospital-Based Cancer Registry in a major city in a low-to middle-income country: the case of Cali, Colombia.

Luis G Parra-Lara, Diana M Mendoza-Urbano, Ángela R Zambrano, Andrea Valencia-Orozco, Juan C Bravo-Ocaña, Luis E Bravo-Ocaña, Fernando Rosso

Abstract read
PubMed Publisher
In one paragraph

Article in Cancer causes & control : CCC, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luis G Parra-LaraCentro de Investigaciones Clínicas (CIC), Fundación Valle del Lili, Cra 98 No. 18-49, 760032, Cali, Colombia. luis.parra@fvl.org.co.ORCID http://orcid.org/0000-0002-4877-1117
Diana M Mendoza-UrbanoCentro de Investigaciones Clínicas (CIC), Fundación Valle del Lili, Cra 98 No. 18-49, 760032, Cali, Colombia.
Ángela R ZambranoServicio de Hemato-Oncología, Departamento de Medicina Interna, Fundación Valle del Lili, Cra 98 No. 18-49, 760032, Cali, Colombia.
Andrea Valencia-OrozcoCentro de Investigaciones Clínicas (CIC), Fundación Valle del Lili, Cra 98 No. 18-49, 760032, Cali, Colombia.
Juan C Bravo-OcañaDepartamento de Patología y Laboratorio Clínico, Fundación Valle del Lili, Cra 98 No. 18-49, 760032, Cali, Colombia.
Luis E Bravo-OcañaRegistro Poblacional de Cáncer de Cali, Departamento de Patología, Facultad de Salud, Universidad del Valle, 760032, Cali, Colombia.
Fernando RossoCentro de Investigaciones Clínicas (CIC), Fundación Valle del Lili, Cra 98 No. 18-49, 760032, Cali, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo describe our experience upon developing and implementing a hospital-based cancer registry (HBCR) in a quaternary-level of care private non-profit academic medical center in Cali, Colombia.

methodsHBCRs capture, in a given institution, every single patient with a confirmed malignancy. In this study, all cases evaluated between 2014 and 2018 were included in the HBCR. In compliance with the International Agency for Research on Cancer recommendations, cases were classified as analytic or non-analytic. Data derived from an exhaustive selection of patients was stored in a computing platform owned by the institution, meeting the 2016 Facility Oncology Registry Data Standards recommendations. Quality control was performed by evaluating comparability, timeliness, validity, and completeness.

resultsA total of 24,405 new cases were registered between 2014 and 2018, from which 4253 (17.4%) died. Among all cases, based on the anatomic location, most common malignancies were breast (n = 1554), thyroid (n = 1346), hematolymphoid (n = 1251), prostatic (n = 805), and colorectal (n = 624). The behavior of the new cases was consistent with an incremental trend.

conclusionUpon implementing the HBCR, major challenges were identified (i.e., a precise definition of cases, the development of processes for capturing new cases, a standardized data collection strategy, and carrying-out an appropriate patient follow-up). Based on our experience, the success of an HBCR largely relies on the interest from the institution, the engagement of stakeholders and financial support, that is, it depends on the adequate access over time to funding, technological, and staffing resources.

Indexed as

HospitalsNeoplasmsColombiaHumansIncomeRegistriesCancer controlCancer RegistryHospital-Based Cancer RegistryLow- and middle-income countries (LMIC)MethodsSurveillance

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.